Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Baricitinib may effectively treat oral lichen planus.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Gefitinib can cause scalp skin issues and permanent hair loss.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.